Trial Profile

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 06 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fosigotifator (Primary)
Indications Amyotrophic lateral sclerosis
Focus Therapeutic Use
Acronyms HEALEY ALS Platform

Most Recent Events

04 Feb 2025 Status changed from recruiting to completed.
06 Jan 2025 According to a Calico media release, analyses on the observed HHD signal and biomarker data are ongoing and will be presented at an upcoming medical meeting.
06 Jan 2025 Results presented in a Calico media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com